HVEM costimulatory domain boosts CAR T cell efficacy against solid tumors via enhanced TRAF-mediated TNF signaling
HVEM enhances CAR T cell efficacy against solid tumors by robustly activating TNF signaling through TRAF recruitment, particularly via the AVEE motif. These findings highlight HVEM as a promising co-stimulatory domain for improving CAR T cell therapy in solid tumors, with implications for metabolic reprogramming and sustained antitumor activity.
Authors
- Yizhou Yao (ORCID: https://orcid.org/0009-0006-6664-0774)
- Haiheng Xu
- Shishuo Sun (ORCID: https://orcid.org/0000-0001-8608-7204)
- Xiaoge Gao (ORCID: https://orcid.org/0000-0003-4858-9398)
- Wanxin Zhao
- Xiaoxiao Liu
- Junnian Zheng
- Patrick Ming-Kuen Tang
- Zhenyu Wang
- Ying Xue
- Yibing Liang
- Qing Zhang
- Yifan Yuan
- Qihong Li
- Hailong Li
Institutions
- Jiangsu University (CN)
- Xuzhou Medical College (CN)
- Chinese University of Hong Kong (HK)
- Soochow University (CN)
- Xuzhou Cancer Hospital (CN)
- First Affiliated Hospital of Soochow University (CN)
Publication Details
- Journal
- Cell Communication and Signaling
- Published
- 2026-01-08
- DOI
- https://doi.org/10.1186/s12964-025-02648-4
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00